Medicalschoolquizzes. Com
patients with sarcoma or hypercalcemia should not be given teriparatide.
Explanation
May 2004 - Adverse event reporting database found 152 cases associated with all bisphophonates.
by itself osteoporosis is painless.
there is now a q3monthly IV option now available. Results are comparable (50%) rductionin vertebral fractures in those with and without fracture history.
There is no data on prevention of other types of fractures.
It is not usually used as a first line drug. It is usually reserved for postmenopausal women who have a very high risk of fracture and those who are unresponsive or intolerant to other osteoporosis medications.
Bisphosphonates are antiresorptive or bone retaining medications.
It is not very effective as monotherapy for future fracture reduction.
This is how they prevent the osteoclasts from resorbing bone.
The rest of the medications are antiresorptives or bone retaining medications.
Patients uder 70 should take 400IU.
Quiz Review Timeline (Updated): +
Our quizzes are rigorously reviewed, monitored and continuously updated by our expert board to maintain accuracy, relevance, and timeliness.